Structures by: Böcskei Z.
Total: 23
C21H32N2O6
C21H32N2O6
Journal of the Chemical Society, Perkin Transactions 2 (2000) 1 149
a=13.288(4)Å b=27.298(5)Å c=6.235(6)Å
α=90.00° β=90.00° γ=90.00°
C22H36N2O2
C22H36N2O2
Journal of the Chemical Society, Perkin Transactions 2 (2000) 1 149
a=13.209(18)Å b=26.587(21)Å c=7.218(21)Å
α=90.00° β=90.00° γ=90.00°
d-trans chrysanthemic acid DMAD salt
C21H32N2O6
Journal of the Chemical Society, Perkin Transactions 2 (2000) 1 149
a=9.923(10)Å b=7.658(10)Å c=15.573(10)Å
α=90.00° β=107.02(10)° γ=90.00°
C16H16ClNO3
C16H16ClNO3
Acta Crystallographica Section B (1996) 52, 1 194-200
a=13.922(6)Å b=6.951(3)Å c=30.173(7)Å
α=90.00° β=93.04(3)° γ=90.00°
C20H26ClNO6
C20H26ClNO6
Acta Crystallographica Section B (1996) 52, 1 194-200
a=12.477(3)Å b=12.646(4)Å c=13.4267(11)Å
α=90.00° β=102.747(12)° γ=90.00°
C18H20ClNO4
C18H20ClNO4
Acta Crystallographica Section B (1996) 52, 1 194-200
a=11.146(4)Å b=12.343(2)Å c=13.737(8)Å
α=90.00° β=107.92(5)° γ=90.00°
Irbesartan
C25H28N6O
Acta Crystallographica Section C (1998) 54, 6 808-810
a=11.170(5)Å b=12.181(4)Å c=9.366(4)Å
α=90.75(4)° β=105.24(4)° γ=112.92(3)°
C17H15N3O
C17H15N3O
Acta Crystallographica Section C (1995) 51, 4 723-726
a=7.423(1)Å b=20.540(1)Å c=9.1829(7)Å
α=90.00° β=101.448(8)° γ=90.00°
C25H25N3O
C25H25N3O
Acta Crystallographica Section C (1995) 51, 4 723-726
a=19.053(6)Å b=11.451(3)Å c=19.309(3)Å
α=90.00° β=96.62(2)° γ=90.00°
C17H23NO7
C17H23NO7
Acta Crystallographica Section C (1996) 52, 2 463-466
a=9.463(5)Å b=42.025(4)Å c=9.089(4)Å
α=90.00° β=90.00° γ=90.00°
Trimethylsilyl N-p-bromo phenyl carbamate
C10H14BrNO2Si
Acta Crystallographica Section C (1996) 52, 8 2063-2066
a=10.303(2)Å b=23.585(3)Å c=5.335(3)Å
α=90° β=90° γ=90°
1-phenyl-2-(propyl-amino)-penthane
C14H24ClN
Acta Crystallographica Section C (1996) 52, 8 2090-2092
a=7.665(1)Å b=14.816(1)Å c=13.237(1)Å
α=90° β=93.830(1)° γ=90°
Trimethylsilyl N-phenyl N-tert-buthyl carbamate
C14H23NO2Si
Acta Crystallographica Section C (1996) 52, 8 2063-2066
a=18.508(5)Å b=6.240(9)Å c=28.128(6)Å
α=90° β=94.57(2)° γ=90°
C18H16O3
C18H16O3
Acta Crystallographica Section C (1996) 52, 4 1022-1024
a=7.000(4)Å b=30.605(5)Å c=7.151(3)Å
α=90.00° β=110.32(4)° γ=90.00°
Depogen
C24H32NO4,C9H9N4O4,H2O
Acta Crystallographica Section C (1995) 51, 8 1587-1590
a=24.612(6)Å b=60.310(8)Å c=9.131(7)Å
α=90.00° β=90.00° γ=90.00°
C30H48O5
C30H48O5
Acta Crystallographica Section C (1996) 52, 5 1302-1304
a=13.926(2)Å b=32.800(4)Å c=6.283(4)Å
α=90° β=90° γ=90°
4-androsten-17beta-yl acetate-3-one
C21H30O3
Acta Crystallographica Section C (1996) 52, 11 2899-2903
a=12.801(4)Å b=18.168(4)Å c=7.866(4)Å
α=90.° β=90.° γ=90.°
Syn-4-androsten-17beta-yl acetate-3-O-benzyloxyme
C28H37NO3
Acta Crystallographica Section C (1996) 52, 11 2899-2903
a=13.507(3)Å b=6.117(5)Å c=15.250(3)Å
α=90.° β=92.582(15)° γ=90.°
Anti-4-androsten-17beta-yl acetate-3-Obenzyloxime
C28H37NO3
Acta Crystallographica Section C (1996) 52, 11 2899-2903
a=10.207(5)Å b=40.174(7)Å c=6.074(13)Å
α=90.° β=90.° γ=90.°
C11H13Cl3O4
C11H13Cl3O4
Acta Crystallographica Section C (1998) 54, 11 1694-1695
a=6.291(2)Å b=11.009(2)Å c=20.1850(11)Å
α=90.00° β=93.939(11)° γ=90.00°
C29H32O3
C29H32O3
Acta Crystallographica Section C (1995) 51, 7 1319-1322
a=19.058(2)Å b=19.209(2)Å c=6.275(1)Å
α=90° β=90° γ=90°
C29H32O3
C29H32O3
Acta Crystallographica Section C (1995) 51, 7 1319-1322
a=19.158(3)Å b=19.029(3)Å c=6.377(2)Å
α=90° β=90° γ=90°
C23H35P
C23H35P
Journal of the American Chemical Society (1997) 119, 5095-5099
a=21.137(4)Å b=22.327(5)Å c=9.149(2)Å
α=90.00° β=90.00° γ=90.00°